Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette)

NCT01164072 | Completed DMC

• 1 other identifier: CAT01/10
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The study's major aim is to investigate the ability of a commercial Electronic Nicotine Delivery Device (E-Cigarette) to induce long-term smoking reduction/abstinence in smokers unwilling to quit. Secondary aims are to investigate changes in withdrawal symptoms and cravings and to examine whether concomitant use of the E-Cigarette and smoking is safe. The study will monitor smoking reduction/abstinence effects, changes in withdrawal symptoms, and adverse events of a currently marketed device in Italy ("Categoria" electronic cigarette - "ORIGINAL" 7.2 mg nicotine cartridges). The primary hypothesis is that the E-Cigarette is a safe device that allows smoking reduction or abstinence in smokers possibly by suppressing withdrawal symptoms and cravings.

Conditions

Healthy Smokers; Smoking Cessation

Keywords

electronic cigarette; nicotine; smoking cessation; smoking reduction

Outcome Measures

Primary Outcomes (2)

• Sustained 50% reduction in the number of cigarettes smoked per day at week-12 from baseline

  50% reduction in the number of cigarettes smoked per day documented at each study visit (week-2, -4, -6, -8, -10, and -12)

  week-12

• Sustained smoking abstinence at week-12

  Sustained smoking abstinence at week-12, defined as complete abstinence from tobacco smoking (not even a puff) for the 14 days period prior to week-12 study visit; exhaled CO levels will be measured to objectively verify smoking status.

  week 12

Secondary Outcomes (7)

• Sustained 80% reduction in the number of cigarettes smoked per day at week-12 from baseline

  week-12

• Sustained smoking abstinence at week-24

  week 24

• Sustained 50% reduction in the number of cigarettes smoked per day at week-24 from baseline

  week-24

• Sustained 80% reduction in the number of cigarettes smoked per day at week-24 from baseline

  week-24

• Withdrawal suppression (by MNWS)

  24 wks

Study Arms (1)

HIGH NICOTINE

Well characterized group of 100 regular smokers experimenting the E-Cigarette loaded with 7.2 mg nicotine cartridges (high nicotine group).

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Regular smokers from Catania in Italy recruited following the placement of an advertisement in a local newspaper.

Sponsors & Collaborators

• Universita degli Studi di Catania: lead
• Lega Italiana Anti Fumo: collaborator
• Arbi Group Srl: collaborator

Study Sites (1)

Dipartimento di Medicina Interna e Specialistica; Centro per la Prevenzione e Cura del Tabagismo (CPCT)

Catania, 95124, Italy

Location

Related Publications (1)

• Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013 Jun 24;8(6):e66317. doi: 10.1371/journal.pone.0066317. Print 2013.

  PMID: 23826093 DERIVED

MeSH Terms

Conditions

Smoking Cessation; Vaping; Smoking Reduction

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Smoking

Study Officials

• Riccardo Polosa, MD, PhD

  Università di Catania

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Internal medicine

Study Record Dates

• First Submitted: July 6, 2010
• First Posted: July 16, 2010
• Study Start: April 1, 2010
• Primary Completion: April 1, 2012
• Study Completion: April 1, 2012
• Last Updated: January 8, 2013

Record last verified: 2013-01

Locations

IT (1)